Vera Therapeutics Statistics Share Statistics Vera Therapeutics has 63.82M
shares outstanding. The number of shares has increased by 16.32%
in one year.
Shares Outstanding 63.82M Shares Change (YoY) 16.32% Shares Change (QoQ) 0.04% Owned by Institutions (%) 97.72% Shares Floating 48.53M Failed to Deliver (FTD) Shares 577 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 7.77M, so 12.18% of the outstanding
shares have been sold short.
Short Interest 7.77M Short % of Shares Out 12.18% Short % of Float 14.04% Short Ratio (days to cover) 4.96
Valuation Ratios The PE ratio is -15.38 and the forward
PE ratio is -5.09.
Vera Therapeutics's PEG ratio is
-0.69.
PE Ratio -15.38 Forward PE -5.09 PS Ratio 0 Forward PS 39.1 PB Ratio 4.05 P/FCF Ratio -17.25 PEG Ratio -0.69
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vera Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 25.67,
with a Debt / Equity ratio of 0.09.
Current Ratio 25.67 Quick Ratio 25.67 Debt / Equity 0.09 Debt / EBITDA -0.33 Debt / FCF -0.4 Interest Coverage -21.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1M Employee Count 152 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -42.61% in the
last 52 weeks. The beta is 1.16, so Vera Therapeutics's
price volatility has been higher than the market average.
Beta 1.16 52-Week Price Change -42.61% 50-Day Moving Average 22.19 200-Day Moving Average 29 Relative Strength Index (RSI) 49.78 Average Volume (20 Days) 1,659,122
Income Statement
Revenue n/a Gross Profit n/a Operating Income -167.17M Net Income -152.15M EBITDA -167.17M EBIT -159.77M Earnings Per Share (EPS) -2.75
Full Income Statement Balance Sheet The company has 92.65M in cash and 54.64M in
debt, giving a net cash position of 38.01M.
Cash & Cash Equivalents 92.65M Total Debt 54.64M Net Cash 38.01M Retained Earnings -461.25M Total Assets 578.53M Working Capital 534.1M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -134.68M
and capital expenditures -972K, giving a free cash flow of -135.65M.
Operating Cash Flow -134.68M Capital Expenditures -972K Free Cash Flow -135.65M FCF Per Share -2.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
